Timely & critical insights across the spectrum of pharma & biotech

HomeCategory

COVID-19 - PharmForward

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/07/PF_Pfizer-640x480.jpg

COVID-19 Patented Drugs & Vaccines

Pfizer and BioNTech Partner with Biovac to supply COVID-19 Vaccine in Africa

July 22, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/05/Novavax-initiates-pediatric-expansion-for-its-COVID-19-vaccine-640x480.jpg

COVID-19 Patented Drugs & Vaccines

Novavax initiates pediatric expansion for its COVID-19 vaccine

May 6, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/03/Covovax-trials-begin-in-India-640x480.jpg

Covovax Trials Begin in India

March 31, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2021/02/More-COVID-19-vaccines-inching-closer-to-markets-announcing-trial-data--640x480.jpg

COVID-19 Patented Drugs & Vaccines

More COVID-19 vaccines inching closer to markets, announcing trial data

February 10, 20210

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/12/Eli-Lilly-and-United-Health-Group-partner-for-COVID-19-study--640x480.jpg

Biosimilar COVID-19

Eli Lilly and United Health Group partner for COVID-19 study

December 10, 20200

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/11/Sputnik-V-COVID-19-vaccine-indicates-91.4-efficacy-from-interim-Phase-3-results--640x480.jpg

COVID-19 Patented Drugs & Vaccines

Sputnik V COVID-19 vaccine indicates 91.4% efficacy from interim Phase 3 results

November 26, 20200

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/11/Merck-Acquires-OncoImmune-for-USD-425-Million--640x480.jpg

Merck Acquires OncoImmune for USD 425 Million

November 26, 20200

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/11/Oxford-Astra-Zeneca-release-interim-results-of-Phase-III-COVID-Vaccine-Trial--640x480.jpg

COVID-19 Patented Drugs & Vaccines

Oxford-Astra Zeneca release interim results of Phase III COVID Vaccine Trial

November 24, 20200

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/11/Moderna-releases-Interim-Phase-III-results-of-its-COVID-19-vaccines-640x480.jpg

COVID-19 Patented Drugs & Vaccines

Moderna releases Interim Phase III results of its COVID-19 vaccines with 94.5% efficacy

November 17, 20200

https://www.sathguru.com/pharmforward/wp-content/uploads/2020/11/Eli-Lillys-Bamlanivimab-Receives-FDA-Emergency-Use-Authorization--640x480.jpg

COVID-19 R & D, Regulatory & Policy

Eli Lilly’s Bamlanivimab Receives FDA Emergency Use Authorization

November 11, 20200